Skip to main content
Top
Published in: Archives of Dermatological Research 1/2024

01-01-2024 | ORIGINAL PAPER

Alternative viewpoint against diabetic wound based on stem cell secretome that can mediated angiogenesis and reduce inflammation

Authors: Rezvan Izadi, Seyed Hesamaldin Hejazi, Seifollah Bahramikia

Published in: Archives of Dermatological Research | Issue 1/2024

Login to get access

Abstract

Diabetes mellitus, as an important metabolic disorder, affects the health of millions of people worldwide. A diabetic wound is one of the complications of diabetes. The stem cell secretome can particularly affect the wound healing process in diabetic wounds. The present study aimed to investigate the effects of Adipose-derived stem cells (ASCs) secretome on the skin wound healing process, angiogenesis, and inflammation in diabetic rats. For this purpose, ASCs were extracted from Adipose tissue and confirmed by flow cytometry and cell differentiation. Secretome was prepared. 27 rats were divided into three groups, non-diabetic, diabetic (treated with phosphate-buffered saline), and diabetics treated with secretome. The levels of vascular endothelial growth factor (VEGF) and transforming growth factor-beta (TGF-β) were examined by the enzyme-linked immunosorbent assay (ELISA) was performed in the skin tissues of all groups. Hematoxylin and eosin (H&E) staining was performed. The level of VEGF was higher in the diabetic group treated with secretome as compared to the other two groups, while the level of TGF-β was lower in this group, compared to the diabetic group. Based on the results of H&E staining, the epidermal thickness and angiogenesis were higher in the diabetic group treated with secretome, whereas edema, number of inflammatory cells, and epidermal damage were lower in this group, compared to the diabetic group. Subcutaneous injection of secretome can lead to diabetic wound healing by increasing growth factors associated with angiogenesis such as VEGF, increasing angiogenesis, regulating TGF-β levels, reducing inflammatory cells.
Literature
1.
go back to reference Bai Q, Han K, Dong K et al (2020) Potential applications of nanomaterials and technology for diabetic wound healing. Int J Nanomed 15:9717–9743CrossRef Bai Q, Han K, Dong K et al (2020) Potential applications of nanomaterials and technology for diabetic wound healing. Int J Nanomed 15:9717–9743CrossRef
8.
go back to reference Trzyna A, Banaś-Ząbczyk A (2021) Adipose-derived stem cells secretome and its potential application in “stem cell-free therapy.” Biomolecules 11:878CrossRefPubMedCentral Trzyna A, Banaś-Ząbczyk A (2021) Adipose-derived stem cells secretome and its potential application in “stem cell-free therapy.” Biomolecules 11:878CrossRefPubMedCentral
28.
go back to reference Jośko J, Gwóźdź B, Jedrzejowska-Szypułka H, Hendryk S (2000) Vascular endothelial growth factor (VEGF) and its effect on angiogenesis. Med Sci Monit 6:1047–1052PubMed Jośko J, Gwóźdź B, Jedrzejowska-Szypułka H, Hendryk S (2000) Vascular endothelial growth factor (VEGF) and its effect on angiogenesis. Med Sci Monit 6:1047–1052PubMed
36.
go back to reference McDonald TA, Zepeda ML, Tomlinson MJ et al (2010) Subcutaneous administration of biotherapeutics: current experience in animal models. Curr Opin Mol Ther 12:461–470PubMed McDonald TA, Zepeda ML, Tomlinson MJ et al (2010) Subcutaneous administration of biotherapeutics: current experience in animal models. Curr Opin Mol Ther 12:461–470PubMed
Metadata
Title
Alternative viewpoint against diabetic wound based on stem cell secretome that can mediated angiogenesis and reduce inflammation
Authors
Rezvan Izadi
Seyed Hesamaldin Hejazi
Seifollah Bahramikia
Publication date
01-01-2024
Publisher
Springer Berlin Heidelberg
Published in
Archives of Dermatological Research / Issue 1/2024
Print ISSN: 0340-3696
Electronic ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-023-02739-7

Other articles of this Issue 1/2024

Archives of Dermatological Research 1/2024 Go to the issue